Hongkong XinRunde Chemical Co., Ltd

 

Reliable Manufacturer and Supplier of Top Quality Pharmaceutical Raw Material and Pharmaceutical Intermediate

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsNootropic Powder

99% Setipiprant 866460-33-5 Pharmaceutical Raw Materials For Anti Hair Loss

99% Setipiprant 866460-33-5 Pharmaceutical Raw Materials For Anti Hair Loss

99% Setipiprant 866460-33-5 Pharmaceutical Raw Materials For Anti Hair Loss
99% Setipiprant 866460-33-5 Pharmaceutical Raw Materials For Anti Hair Loss

Large Image :  99% Setipiprant 866460-33-5 Pharmaceutical Raw Materials For Anti Hair Loss Get Best Price

Product Details:

Place of Origin: China
Brand Name: XRD
Certification: GMP
Model Number: 866460-33-5

Payment & Shipping Terms:

Minimum Order Quantity: negotiable
Price: Negotiable
Packaging Details: 1-2 kg / aluminum foil bag, 25kg/ drum, as required
Delivery Time: 5-7 days after received your payments
Payment Terms: T/T bank, Western Union, Bitcoin, Etc
Supply Ability: 100KG/ Month
Detailed Product Description
CAS: 866460-33-5 Product Name: 2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic Acid
Type: Pharmaceutical Intermediate Appearance: White Powder
Usage: For Anti Hair Loss Alias: Setipiprant
Assay: 99.5% Key Words: Setipiprant
High Light:

brain nootropics

,

memory enhancing supplements

 

99% Setipiprant 866460-33-5 Pharmaceutical Raw Materials For Anti Hair Loss

Quick Details

Product name: Setipiprant
CAS NO: 866460-33-5
Purity:99%
MF :C24H19FN2O3
Grade: Medicine Grade ° C

 

Setipiprant (INN) is a drug originally developed by Actelion which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients, it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.

 

A phase 2A study is underway to evaluate the safety, tolerability, and efficacy of oral setipiprant relative to a placebo and the active comparator, finasteride, in 18 to 41 years old males with androgenetic alopecia.

 
Functions
 

Setipiprant is the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of Setipiprant have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery.

99% Setipiprant 866460-33-5 Pharmaceutical Raw Materials For Anti Hair Loss 0

 

99% Setipiprant 866460-33-5 Pharmaceutical Raw Materials For Anti Hair Loss

 

Contact Details
Hongkong XinRunde Chemical Co., Ltd

Contact Person: Linda Yang

Tel: +8618874586545

Send your inquiry directly to us